A 2.6% reduction in hip bone mineral density and a 2.1% reduction at the lumbar spine in 52 weeks (Hansen et al., 2024), combined with up to 10.9% lean mass loss over 72 weeks (Look et al., 2025), means that patients on GLP-1 therapy need a comprehensive musculoskeletal protection plan from day one
BBB restrictions: The BBB serves as a barrier that hampers the passage of specific phytochemicals into the brain, posing a challenge for these compounds to exert their neuroprotective effects directly at the injury site
CaloriBurn GP grains of paradise extract supports thermogenic activity and calorie utilization, while chromium picolinate remains a trusted nutrient associated with insulin function and metabolic efficiency

Check Out Our 5 Star Reviews Additional Services You May Need Body Contouring Botox & Fillers Bellafill Chemical Peels Dysport HydraFacials Juvederm Kybella Laser Hair Removal Laser Fat Removal Laser Tattoo Removal Laser Freckle Removal Laser Mole Removal Zerona Laser Lipo CO2 Laser Treatment Trap Tox Additional Services You May Need Body Contouring Botox & Fillers Bellafill Chemical Peels Dysport HydraFacials Juvederm Kybella Laser Hair Removal Laser Fat Removal Laser Tattoo Removal Microneedling PDO Thread Lift Restylane Revanesse Versa Skin Care Skin Tightening Splendor X Laser Teeth Whitening Ultherapy Treatment Xeomin Laser Freckle Removal Laser Mole Removal PicoWay Resolve PicoWay Laser Varicose Veins Leg Veins Spider Veins Morpheus 8 Tightening Waxing VI Peel Semaglutide GLP-1 Acne Treatment AviClear BioRePeel Vitamin B12 Shots EMSculpt Exilis Dermal Fillers Zerona Laser Lipo Vamp Salmon DNA Non-Surgical Breast Lift CO2 Laser Treatment EmFemme 360 Body Sculpting Trap Tox Collagen Banking

Any patient with a history of peptic ulcer disease, chronic kidney disease stage 3 or higher, or known gastroparesis should avoid NSAIDs entirely during GLP-1 therapy and discuss alternatives with their prescriber [15]
The peptide has been studied in laboratory and preclinical settings and is used in cosmetics, but it has not completed the FDA drug-approval process for a medical indication